BCL9/9L-β-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer

EBioMedicine

Volumn 2, Issue 12, 2015, Pages 1932-1943

  Moor, Andreas E ^a   Anderle, Pascale ^b   Cantù, Claudio ^c   Rodriguez, Patrick ^a   Wiedemann, Norbert ^a   Baruthio, Frédérique ^a   Deka, Jürgen ^a   André, Sylvie ^a   Valenta, Tomas ^c   Moor, Matthias B ^d   Gyorffy, Balázs ^e   Barras, David ^b   Delorenzi, Mauro ^b,d   Basler, Konrad ^c   Aguet, Michel ^a  

^a EPFL   (Switzerland)

^b SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

BCL9 9L catenin; Cancer stem cells; Colorectal cancer subtypes; Patient outcome; WNT signaling

Indexed keywords

PEPTIDES AND PROTEINS; PROTEIN BCL 9; PROTEIN BCL 9L BETA CATENIN; UNCLASSIFIED DRUG; VIMENTIN; BCL9 PROTEIN, HUMAN; BETA CATENIN; TRANSCRIPTOME; TUMOR PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CELL PROLIFERATION; CLINICAL TRIAL (TOPIC); COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RNA SEQUENCE; SIGNAL TRANSDUCTION; UPREGULATION; WNT SIGNALING PATHWAY; ANIMAL; ANTAGONISTS AND INHIBITORS; CANCER STEM CELL; CELL TRANSFORMATION; CLUSTER ANALYSIS; COLORECTAL TUMOR; DISEASE MODEL; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; INFORMATION PROCESSING; KNOCKOUT MOUSE; METABOLISM; MORTALITY; PATHOLOGY; PHENOTYPE;

ANIMALS; BETA CATENIN; CELL TRANSFORMATION, NEOPLASTIC; CLUSTER ANALYSIS; COLORECTAL NEOPLASMS; DATASETS AS TOPIC; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKOUT TECHNIQUES; HUMANS; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; PHENOTYPE; PROGNOSIS; SEQUENCE DELETION; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84958936547     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2015.10.030     Document Type: Article

References (61)

1. Anastas J.N., Moon R.T. WNT signalling pathways as therapeutic targets in cancer. Nat. Rev. Cancer 2013, 13(1):11-26. 10.1038/nrc3419.
2. Biechele S., Cox B.J., Rossant J. Porcupine homolog is required for canonical Wnt signaling and gastrulation in mouse embryos. Dev. Biol. 2011, 355(2):275-285. 10.1016/j.ydbio.2011.04.029.
3. Brack A.S., Murphy-Seiler F., Hanifi J., et al. BCL9 is an essential component of canonical Wnt signaling that mediates the differentiation of myogenic progenitors during muscle regeneration. Dev. Biol. 2009, 335(1):93-105. 10.1016/j.ydbio.2009.08.014.
4. Brembeck F.H., Rosario M., Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr. Opin. Genet. Dev. 2006, 16(1):51-59. 10.1016/j.gde.2005.12.007.
5. Brembeck F.H., Schwarz-Romond T., Bakkers J., et al. Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions. Genes Dev. 2004, 18(18):2225-2230. 10.1101/gad.317604.
6. Budinska E., Popovici V., Tejpar S., et al. Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer. J. Pathol. 2013, 231(1):63-76. 10.1002/path.4212.
7. Cancer Genome Atlas N. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012, 487(7407):330-337. 10.1038/nature11252.
8. Cantù C., Zimmerli D., Hausmann G., et al. Pax6-dependent, but beta-catenin-independent, function of Bcl9 proteins in mouse lens development. Genes Dev. 2014, 28(17):1879-1884. 10.1101/gad.246140.114.
9. Christensen J., El-Gebali S., Natoli M., et al. Defining new criteria for selection of cell-based intestinal models using publicly available databases. BMC Genomics 2012, 13:274-284. 10.1186/1471-2164-13-274.
10. Clevers H. The intestinal crypt, a prototype stem cell compartment. Cell 2013, 154(2):274-284. 10.1016/j. cell.2013.07.004.
11. Dalerba P., Kalisky T., Sahoo D., et al. Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat. Biotechnol. 2011, 29(12):1120-1127. 10.1038/nbt.2038.
12. de la Roche M., Rutherford T.J., Gupta D., et al. An intrinsically labile alpha-helix abutting the BCL9-binding site of beta-catenin is required for its inhibition by carnosic acid. Nat. Commun. 2012, 3:680. 10.1038/ncomms1680.
13. Deka J., Wiedemann N., Anderle P., et al. Bcl9/Bcl9l Are Critical for Wnt-Mediated Regulation of Stem Cell Traits in Colon Epithelium and Adenocarcinomas. Cancer Res. 2010, 70(16):6619-6628. 10.1158/0008-5472.CAN-10-0148.
14. Dow L.E., O'Rourke K.P., Simon J., et al. Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer. Cell 2015, 161(7):1539-1552. 10.1016/j.cell.2015.05.033.
15. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61(5):759-767. http://www.ncbi.nlm.nih.gov/pubmed/2188735.
16. Fevr T., Robine S., Louvard D., et al. Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells. Mol. Cell. Biol. 2007, 27(21):7551-7559. 10.1128/MCB.01034-07.
17. Fu J., Jiang M., Mirando A.J., et al. Reciprocal regulation of Wnt and Gpr177/mouse Wntless is required for embryonic axis formation. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(44):18598-18603. 10.1073/pnas.0904894106.
18. Gotzmann J., Fischer A.N., Zojer M., et al. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes. Oncogene 2006, 25(22):3170-3185. 10.1038/sj.onc.1209083.
19. Greten F.R., Eckmann L., Greten T.F., et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004, 118(3):285-296. 10.1016/j. cell.2004.07.013.
20. Groger C.J., Grubinger M., Waldhor T., et al. Meta-analysis of gene expression signatures defining the epithelial to mesenchymal transition during cancer progression. PLoS One 2012, 7(12):e51136. 10.1371/journal.pone.0051136.
21. Guinney J., Dienstmann R., Wang X., et al. The consensus molecular subtypes of colorectal cancer. Nat. Med. 2015, 10.1038/nm.3967.
22. Hoffmans R., Stadeli R., Basler K. Pygopus and legless provide essential transcriptional coactivator functions to armadillo/beta-catenin. Curr. Biol. 2005, 15(13):1207-1211. 10.1016/j.cub.2005.05.054.
23. Hoggard L.R., Zhang Y., Zhang M., et al. Rational Design of Selective Small-Molecule Inhibitors for beta-Catenin/B-Cell Lymphoma 9 Protein-Protein Interactions. J. Am. Chem. Soc. 2015, 137(38):12249-12260. 10.1021/jacs.5b04988.
24. Ireland H., Kemp R., Houghton C., et al. Inducible Cre-mediated control of gene expression in the murine gastrointestinal tract: effect of loss of beta-catenin. Gastroenterology 2004, 126(5):1236-1246. http://dx.doi.org/S0016508504004500 [pii].
25. Janssen K.P., Alberici P., Fsihi H., et al. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Gastroenterology 2006, 131(4):1096-1109. 10.1053/j.gastro.2006.08.011.
26. Korinek V., Barker N., Moerer P., et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Genet. 1998, 19(4):379-383. 10.1038/1270.
27. Kosinski C., Li V.S., Chan A.S., et al. Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(39):15418-15423. 10.1073/pnas.0707210104.
28. Kramps T., Peter O., Brunner E., et al. Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex. Cell 2002, 109(1):47-60. http://dx.doi.org/S0092867402006797 [pii].
29. Li Q., Birkbak N.J., Gyorffy B., et al. Jetset: selecting the optimal microarray probe set to represent a gene. BMC Bioinf. 2011, 12:474. 10.1186/1471-2105-12-474.
30. Mani M., Carrasco D.E., Zhang Y., et al. BCL9 Promotes Tumor Progression by Conferring Enhanced Proliferative, Metastatic, and Angiogenic Properties to Cancer Cells. Cancer Res. 2009, 10.1158/0008-5472.CAN-09-0773.
31. Marisa L., de Reynies A., Duval A., et al. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med. 2013, 10(5):e1001453. 10.1371/journal.pmed.1001453.
32. Merlos-Suarez A., Barriga F.M., Jung P., et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 2011, 8(5):511-524. 10.1016/j.stem.2011.02.020.
33. Mosimann C., Hausmann G., Basler K. Beta-catenin hits chromatin: regulation of Wnt target gene activation. Nat. Rev. Mol. Cell Biol. 2009, 10(4):276-286. 10.1038/nrm2654.
34. Munoz J., Stange D.E., Schepers A.G., et al. The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markers. EMBO J. 2012, 31(14):3079-3091. 10.1038/emboj.2012.166.
35. Natoli M., Christensen J., El-Gebali S., et al. The role of CDX2 in Caco-2 cell differentiation. Eur. J. Pharm. Biopharm. 2013, 85(1):20-25. 10.1016/j.ejpb.2013.03.018.
36. Neufert C., Becker C., Neurath M.F. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat. Protoc. 2007, 2(8):1998-2004. 10.1038/nprot.2007.279.
37. Nguyen L.V., Vanner R., Dirks P., et al. Cancer stem cells: an evolving concept. Nat. Rev. Cancer 2012, 12(2):133-143. 10.1038/nrc3184.
38. Popovici V., Budinska E., Tejpar S., et al. Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancer. J. Clin. Oncol. 2012, 30(12):1288-1295. 10.1200/JCO.2011.39.5814.
39. Powell A.E., Wang Y., Li Y., et al. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell 2012, 149(1):146-158. 10.1016/j.cell.2012.02.042.
40. Ring A., Kim Y.M., Kahn M. Wnt/catenin signaling in adult stem cell physiology and disease. Stem Cell Rev. 2014, 10(4):512-525. 10.1007/s12015-014-9515-2.
41. Rosin-Arbesfeld R., Cliffe A., Brabletz T., et al. Nuclear export of the APC tumour suppressor controls beta-catenin function in transcription. EMBO J. 2003, 22(5):1101-1113. 10.1093/emboj/cdg105.
42. Sadanandam A., Lyssiotis C.A., Homicsko K., et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat. Med. 2013, 19(5):619-625. 10.1038/nm.3175.
43. Sampietro J., Dahlberg C.L., Cho U.S., et al. Crystal structure of a beta-catenin/BCL9/Tcf4 complex. Mol. Cell 2006, 24(2):293-300. 10.1016/j.molcel.2006.09.001.
44. Sansom O.J., Reed K.R., Hayes A.J., et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev. 2004, 18(12):1385-1390. 10.1101/gad.287404.
45. Sato T., Stange D.E., Ferrante M., et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology 2011, 141(5):1762-1772. 10.1053/j.gastro.2011.07.050.
46. Sato T., van Es J.H., Snippert H.J., et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 2011, 469(7330):415-418. 10.1038/nature09637.
47. Schuijers J., Junker J.P., Mokry M., et al. Ascl2 Acts as an R-spondin/Wnt-Responsive Switch to Control Stemness in Intestinal Crypts. Cell Stem Cell 2015, 10.1016/j.stem.2014.12.006.
48. Subramanian A., Tamayo P., Mootha V.K., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(43):15545-15550. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16199517.
49. Takada K., Zhu D., Bird G.H., et al. Targeted Disruption of the BCL9/beta-Catenin Complex Inhibits Oncogenic Wnt Signaling. Sci. Transl. Med. 2012, 4(148):148ra117. 10.1126/scitranslmed.3003808.
50. Taketo M.M., Edelmann W. Mouse models of colon cancer. Gastroenterology 2009, 136(3):780-798. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19263594.
51. Taube J.H., Herschkowitz J.I., Komurov K., et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(35):15449-15454. 10.1073/pnas.1004900107.
52. Valenta T., Hausmann G., Basler K. The many faces and functions of beta-catenin. EMBO J. 2012, 31(12):2714-2736. 10.1038/emboj.2012.150.
53. Van Cutsem E., Labianca R., Bodoky G., et al. Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3. J. Clin. Oncol. 2009, 27(19):3117-3125. 10.1200/JCO.2008.21.6663.
54. Van der Flier L.G., Sabates-Bellver J., Oving I., et al. The Intestinal Wnt/TCF Signature. Gastroenterology 2007, 132(2):628-632. 10.1053/j.gastro.2006.08.039.
55. van der Flier L.G., van Gijn M.E., Hatzis P., et al. Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell 2009, 136(5):903-912. 10.1016/j. cell.2009.01.031.
56. van Es J.H., Clevers H. Generation and Analysis of Mouse Intestinal Tumors and Organoids Harboring APC and K-Ras Mutations. Methods Mol. Biol. 2015, 1267:125-144. 10.1007/978-1-4939-2297-0_6.
57. van Es J.H., Haegebarth A., Kujala P., et al. A critical role for the Wnt effector Tcf4 in adult intestinal homeostatic self-renewal. Mol. Cell. Biol. 2012, 32(10):1918-1927. 10.1128/MCB.06288-11.
58. Ventura A., Kirsch D.G., McLaughlin M.E., et al. Restoration of p53 function leads to tumour regression in vivo. Nature 2007, 445(7128):661-665. 10.1038/nature05541.
59. Watanabe K., Biesinger J., Salmans M.L., et al. Integrative ChIP-seq/microarray analysis identifies a CTNNB1 target signature enriched in intestinal stem cells and colon cancer. PLoS One 2014, 9(3):e92317. 10.1371/journal.pone.0092317.
60. Wong V.W., Stange D.E., Page M.E., et al. Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling. Nat. Cell Biol. 2012, 14(4):401-408. 10.1038/ncb2464.
61. Zeuner A., Todaro M., Stassi G., et al. Colorectal cancer stem cells: From the crypt to the clinic. Cell Stem Cell 2014, 15(6):692-705. 10.1016/j.stem.2014.11.012.